Product Information

TELMISARTAN 40 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1536 per EA under NDC 62332008830. Its NADAC has been published 527 times since Jul 20, 2016.

FDA first approved this application on Jul 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN 40 MG TABLET

Telmisartan
$0.1536per EA

Strength

40 mg/1

NDC

62332008830

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TELMISARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA202130

FDA Approved

7/7/2014

TE Code

AB

On Market Since

6/25/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for TELMISARTAN 40 MG TABLET has been published 527 times since Jul 20, 2016, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1536 per EA
All-time high$0.6750 (Sep 11, 2019)
All-time low$0.1274 (Nov 20, 2024)
52-week high$0.1808
52-week low$0.1519
Median price$0.3571
Average price$0.3507
Largest weekly change-33.0% (Nov 20, 2024)
Weeks tracked527
Tracking sinceJul 20, 2016

Price History

1W

+1.1%

1M

+1.1%

3M

-11.4%

6M

-10.1%

1Y

-13.8%

3Y

-38.4%

5Y

-53.0%

All

-73.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1536 per EA (NDC 62332008830), effective Aug 19, 2026.

How has the price of TELMISARTAN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 73.8%. It has been tracked across 527 weekly CMS publications since Jul 20, 2016.

What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?

Since Jul 20, 2016, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.1274 (Nov 20, 2024) to a high of $0.6750 (Sep 11, 2019), with a median of $0.3571 per EA.

Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN 40 MG TABLET?

TELMISARTAN 40 MG TABLET (NDC 62332008830) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.